Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/1/e004865corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583484883861504
collection DOAJ
format Article
id doaj-art-86951b1690b74deb9d10b1705222fee3
institution Kabale University
issn 2056-5933
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-86951b1690b74deb9d10b1705222fee32025-01-28T12:20:12ZengBMJ Publishing GroupRMD Open2056-59332025-01-0111110.1136/rmdopen-2024-004865corr1Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trialhttps://rmdopen.bmj.com/content/11/1/e004865corr1.full
spellingShingle Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
RMD Open
title Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
title_full Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
title_fullStr Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
title_full_unstemmed Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
title_short Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
title_sort correction efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis a multicentre randomised double blind placebo controlled phase ii clinical trial
url https://rmdopen.bmj.com/content/11/1/e004865corr1.full